Data gathered: May 17
Alternative Data for Vertex Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 331 | Sign up | Sign up | Sign up |
| Sentiment | 91 | Sign up | Sign up | Sign up |
| Webpage traffic | 199,000 | Sign up | Sign up | Sign up |
| Employee Rating | 85 | Sign up | Sign up | Sign up |
| Google Trends | 23 | Sign up | Sign up | Sign up |
| Patents | 283 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Instagram Followers | 10,239 | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 4 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 11,170 | Sign up | Sign up | Sign up |
| Twitter Followers | 72,294 | Sign up | Sign up | Sign up |
| Twitter Mentions | 74 | Sign up | Sign up | Sign up |
| Youtube Subscribers | 2,040 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | 52 | Sign up | Sign up | Sign up |
| ESG | 68 | Sign up | Sign up | Sign up |
| Business Outlook | 90 | Sign up | Sign up | Sign up |
| Linkedin Employees | 5,393 | Sign up | Sign up | Sign up |
About Vertex Pharmaceuticals
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
| Price | $440.64 |
| Target Price | Sign up |
| Volume | 1,220,000 |
| Market Cap | $113B |
| Year Range | $343 - $446.08 |
| Dividend Yield | 0% |
| PE Ratio | 28.41 |
| Revenue per Employee | $2,108,333 |
| Industry | Biotechnology |
In the news
Pfizer, Freeport-McMoRan, Vertex Pharmaceuticals And A Major Tech Stock On CNBC's 'Final Trades'May 14 - Benzinga |
|
Vertex Pharmaceuticals Takes Over #81 Spot From NikeMay 14 - The Online Investor |
|
Vertex Pharmaceuticals's Options Frenzy: What You Need to KnowMay 14 - Benzinga |
|
 |
Here's Why Vertex Pharmaceuticals (VRTX) is a Strong Growth StockMay 13 - Yahoo |
Unveiling Vertex Pharmaceuticals (VRTX)'s Market Value: A Comprehensive GuideMay 13 - GuruFocus |
|
Here's How Much You Would Have Made Owning Vertex Pharmaceuticals Stock In The Last 10 YearsMay 13 - Benzinga |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q1 '24 | 2.68B | 685M | 1.99B | 1.1B | 1.14B | 4.760 |
| Q4 '23 | 2.49B | 782M | 1.7B | 969M | 1.02B | 3.920 |
| Q3 '23 | 2.47B | 583M | 1.89B | 1.04B | 1.24B | 4.080 |
| Q2 '23 | 2.48B | 571M | 1.91B | 916M | 1.28B | 3.890 |
| Q1 '23 | 2.36B | 508M | 1.86B | 700M | 1.25B | 3.050 |
Insider Transactions View All
| Bhatia Sangeeta N. filed to sell 4,435 shares at $403. May 3 '24 |
| Ambrose Kristen filed to sell 7,500 shares at $419. April 3 '24 |
| Ambrose Kristen filed to sell 7,965 shares at $425.7. February 27 '24 |
| Atkinson Edward Morrow III filed to sell 15,972 shares at $425.7. February 27 '24 |
| Tatsis Ourania filed to sell 55,804 shares at $425.7. February 27 '24 |
Similar companies
Congress Trading View All
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| Rohit Khanna Democrat |
Nov 8, 23 | Buy | $1K - $15K |
| Gregory Stanton Democrat |
Nov 9, 23 | Sell | $1K - $15K |
| Gregory Stanton Democrat |
Nov 9, 23 | Buy | $1K - $15K |
Read more about Vertex Pharmaceuticals (VRTX) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, instagram followers, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, youtube subscribers, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Vertex Pharmaceuticals?
The Market Cap of Vertex Pharmaceuticals is $113B.
What is Vertex Pharmaceuticals' PE Ratio?
As of today, Vertex Pharmaceuticals' PE (Price to Earnings) ratio is 28.41.
How Many People Work at Vertex Pharmaceuticals?
As of our latest update, Vertex Pharmaceuticals employed approximately 4,800 people worldwide. However, it's important to note that Vertex Pharmaceuticals' workforce size can fluctuate due to the company's growth, restructuring, or strategic shifts, so the current number of employees may be different.
What is Vertex Pharmaceuticals' revenue per employee?
$2,108,333. To calculate Vertex Pharmaceuticals' revenue per employee, we divide the company's total revenue in the last 4 quarters by its total number of employees.
What is the current stock price of Vertex Pharmaceuticals?
Currently, the price of one share of Vertex Pharmaceuticals stock is $440.64.
How can I analyze the VRTX stock price chart for investment decisions?
The VRTX stock price chart above provides a comprehensive visual representation of Vertex Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Vertex Pharmaceuticals shares. Our platform offers an up-to-date VRTX stock price chart, along with technical data analysis and alternative data insights.
Does VRTX offer dividends to its shareholders?
As of our latest update, Vertex Pharmaceuticals (VRTX) does not offer dividends to its shareholders. Investors interested in Vertex Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Vertex Pharmaceuticals?
Some of the similar stocks of Vertex Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.